FDA Grants Breakthrough Therapy Designation to Magrolimab for MDS Treatment

[Anonymous]

ONCOLOGY-NEW YORK, 2020; 34 (10): 430

Abstract

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索